Institutional investors purchased a net $8.5 million shares of BMY during the quarter ended December 2014 and now own 73.11% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CREDIT SUISSE AG Bought 98.1 Thousand shares of Bristol-Myers Squibb
STANDARD LIFE INVESTMENTS LTD. Bought 80.0 Thousand shares of Bristol-Myers Squibb
SWISSCANTO ASSET MANAGEMENT AG Bought 71.8 Thousand shares of Bristol-Myers Squibb